Clinical Trials Browser

Phase 1/2 × Melanoma × Palonosetron × Clear all

NCT00412425 2012-05-04

Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting

Phase 1/2 Completed

30 enrolled 4 charts

Anorexia, Melanoma, Nausea, Vomiting, Weight Loss